Trial Profile
Efficacy of dermatan sulfate low molecular weight [desmin] + troxerutin + Centella asiatica + Melilotus officinalis in type 2 diabetic patients with diabetic cystoid macular oedema without macular thickening.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 02 Jun 2011
Price :
$35
*
At a glance
- Drugs Dermatan sulfate low molecular weight (Primary) ; Centella asiatica; Melilotus officinalis; Troxerutin
- Indications Diabetic macular oedema
- Focus Therapeutic Use
- 02 Jun 2011 New trial record